Patent ID: 11926614
Assignee: OSLO UNIVERSITETSSYKEHUS HF
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 22:
23. A method of treatment of a disease or disorder responsive to inhibition of tankyrase 1 and/or 2, wherein said disease or disorder is a tumor emerging from colorectal tissue, uterus, pancreas, skin, liver, thyroid, prostate, ovary, stomach, lung, lymphoid, bladder, cervix, thyroid, head and neck, brain, breast or kidney; melanoma; non-regenerative wound healing; or viral infections, fibrosis, or metabolic conditions, said method comprising the step of administering a compound as claimed in claim 1, or a tautomer, a stereoisomer, a pharmaceutically acceptable salt, or pro-drug thereof.